A novel pipeline of AI and simulation tools may make the process of screening drug candidates for COVID-19 50,000 times faster.
To find a drug that can stop the SARS-CoV-2 virus, scientists want to screen billions of molecules for the right combination of properties. The process is usually risky and slow, often taking several years. However, an international team of scientists say they’ve found a way to make the process 50,000 times faster using artificial intelligence (AI). Click here to learn more.